Skip to main content
Premium Trial:

Request an Annual Quote

Food Safety Center to Team with Agilent on Testing Methods

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Center for Food Safety and Technology will collaborate with Agilent Technologies and use a range of the company's life sciences tools to develop new testing methods for monitoring global food supply chains, Agilent said today.

Under the agreement, the NCFST will install a number of Agilent's technologies in its lab in Summit Argo, Ill., and Agilent will provide training and applications support from its food industry group.

"We're putting powerful analytical and biological tools into the hands of some very bright scientists from academia, industry and government, where their combined perspectives should produce creative solutions," Mike McMullen, president of Agilent's Chemical Analysis Group, said in a statement.

NCFST is a research consortium that includes the US Food and Drug Administraton's Center for Food Safety and Applied Nutrition, the Illinois Institute of Technology, and food industry partners.

Through the collaboration, NCFST will install Agilent's 2100 Bioanalyzer; a 7700 inductively-coupled-plasma MS; a 6500 Accurate Mass quadrupole time-of-flight MS; a 6400 triple quadrupole liquid chromatograph/mass spectrometer; a 7000B triple quadrupole gas chromatograph mass spectrometer; a 1290 Infinity ultra high-performance liquid chromatograph; a 5975B GC/MS; and a 7890 GC.

The Agilent systems will give NCFST "greater capability to study chemical compounds of critical concern to the global food industry and regulatory authorities," NCFST's Director of Chemistry, Jack Cappozzo, said in a statement.

Capozzo said that the compounds for which it is testing include melamine, aflatoxins, pesticides, antibiotic residues, and Clostridium botulinum toxin.

Financial terms of the agreement were not released.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.